SCHEMBL20008658

SCHEMBL20008658

CC(C)(C)Cc1c(OC(=O)c2ccc(NC(=N)N)cc2)ccc2cc(C(=N)N)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 15/20 0.47
PLAU P00749 9/20 0.47
PLG P00747 9/20 0.47
PLAT P00750 6/20 0.47
F2 P00734 6/20 0.47
KLKB1 P03952 5/20 0.47
TMPRSS15 P98073 9/20 0.43
KLK1 P06870 4/20 0.40
FTO Q9C0B1 1/20 0.39
TMPRSS2 O15393 1/20 0.38
MLNR O43193 1/20 0.38
ALDH1A1 P00352 1/20 0.38
C1R P00736 1/20 0.38
F10 P00742 1/20 0.38
F12 P00748 1/20 0.38
LMNA P02545 1/20 0.38
ITGB3 P05106 1/20 0.38
HPN P05981 1/20 0.38
CHRM2 P08172 1/20 0.38
ITGA2B P08514 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20008704 0.88 PRSS1 (0.42) PRSS1PLAUPLGPLATF2
SCHEMBL7562225 0.85 FTO (0.46) PRSS1PLAUPLGPLATF2
Hydrochloric Acid SCHEMBL7562340 0.85 FTO (0.46) PRSS1PLAUPLGPLATF2
SCHEMBL7564449 0.85 FTO (0.45) PRSS1PLAUPLGPLATF2
SCHEMBL7562640 0.83 FTO (0.46) PRSS1PLAUPLGPLATF2
Hydrochloric Acid SCHEMBL7564878 0.83 PRSS1 (0.44) PRSS1PLAUPLGPLATF2
SCHEMBL20008653 0.83 PLAU (0.51) PRSS1PLAUPLGPLATF2
Hydrochloric Acid SCHEMBL7565395 0.83 FTO (0.45) PRSS1PLAUPLGPLATF2
Hydrochloric Acid SCHEMBL7562687 0.80 PLAU (0.46) PRSS1PLAUPLGPLATF2
SCHEMBL20008654 0.80 FTO (0.45) PRSS1PLAUPLGPLATF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180085366-A1 OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE ELYSIUM THERAPEUTICS, INC. 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180085366-A1 OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE OPRM1, OPRK1, OPRD1 PRSS1 952/4885PLAU 1879/4885PLG 1237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.